Medicare Enrolled
Dr. Sheila Vasan, M.D.
Hematology & Oncology · Van Nuys, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vasan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vasan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vasan
Dr. Sheila Vasan is a hematology & oncology specialist in Van Nuys, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Vasan performed 4,195 Medicare services across 864 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vasan received a total of $39,536 from 95 pharmaceutical and/or device companies across 1592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vasan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 34% volume in CA
$39,536 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,195
Medicare services
Top 34% in CA for hematology & oncology
864
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~233 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
810 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
799 | $100 | $403 |
| Anti-nausea injection (ondansetron/Zofran) | 438 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 371 | $1 | $3 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
259 | $66 | $244 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
213 | $4 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
211 | $11 | $48 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
170 | $1 | $4 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
135 | $8 | $25 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
131 | $117 | $467 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
126 | $25 | $101 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
116 | $0 | $2 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
81 | $57 | $226 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
73 | $27 | $117 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
61 | $8 | $22 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
55 | $145 | $572 |
| New patient office visit, complex (60-74 min) | 49 | $158 | $720 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $75 | $267 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
48 | $100 | $362 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.1% high complexity
48.1% medium
39.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$39,536
Total received (2018-2024)
Avg $5,648/year across 7 years
Top 14% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
95
Companies
1,592
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$34,886 (88.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,921 (4.9%)
Other
Charitable contributions, space rental, and other categories
$1,683 (4.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,046 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,577
2023
$5,543
2022
$5,118
2021
$4,701
2020
$7,462
2019
$5,667
2018
$4,468
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$938
AstraZeneca Pharmaceuticals LP
$535
Janssen Biotech, Inc.
$512
PFIZER INC.
$348
Incyte Corporation
$322
Merck Sharp & Dohme LLC
$298
E.R. Squibb & Sons, L.L.C.
$262
Eisai Inc.
$240
Astellas Pharma US Inc
$165
Daiichi Sankyo Inc.
$165
Gilead Sciences, Inc.
$164
Celgene Corporation
$157
ABBVIE INC.
$143
Takeda Pharmaceuticals U.S.A., Inc.
$143
PharmaEssentia USA Corporation
$142
Ipsen Biopharmaceuticals, Inc
$133
Lilly USA, LLC
$125
TAIHO ONCOLOGY, INC.
$119
EMD Serono, Inc.
$119
ARRAY BIOPHARMA INC
$111
PUMA BIOTECHNOLOGY, INC.
$107
Karyopharm Therapeutics Inc.
$107
Genentech USA, Inc.
$100
Bayer Healthcare Pharmaceuticals Inc.
$78
Genmab U.S., Inc.
$78
Stemline Therapeutics Inc.
$75
Regeneron Healthcare Solutions, Inc.
$74
TerSera Therapeutics LLC
$73
GlaxoSmithKline, LLC.
$73
Blueprint Medicines Corporation
$70
Agios Pharmaceuticals, Inc.
$58
Alexion Pharmaceuticals, Inc.
$58
INTUITIVE SURGICAL, INC.
$56
Deciphera Pharmaceuticals Inc.
$56
Exelixis Inc.
$46
GENZYME CORPORATION
$44
Mirati Therapeutics, Inc.
$35
Immunocore Limited
$32
Kite Pharma, Inc.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$28
SpringWorks Therapeutics, Inc.
$26
ImmunoGen, Inc.
$23
JAZZ PHARMACEUTICALS INC.
$21
Fennec Pharmaceuticals, Inc.
$19
Teva Pharmaceuticals USA, Inc.
$18
Pharmacosmos Therapeutics Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$17
Cumberland Pharmaceuticals, Inc.
$16
Top 3 companies account for 30.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$4,225
E.R. Squibb & Sons, L.L.C.
$2,328
Karyopharm Therapeutics Inc.
$2,120
AstraZeneca Pharmaceuticals LP
$2,058
PFIZER INC.
$1,888
Incyte Corporation
$1,857
Genentech USA, Inc.
$1,397
Puma Biotechnology, Inc.
$1,333
Amgen Inc.
$1,083
Janssen Biotech, Inc.
$1,076
Celgene Corporation
$1,020
Takeda Pharmaceuticals U.S.A., Inc.
$1,006
GENZYME CORPORATION
$1,000
Astellas Pharma US Inc
$922
Seagen Inc.
$882
Exelixis Inc.
$833
Merck Sharp & Dohme Corporation
$790
Merck Sharp & Dohme LLC
$743
Eisai Inc.
$662
Alexion Pharmaceuticals, Inc.
$645
Lilly USA, LLC
$625
GlaxoSmithKline, LLC.
$612
Daiichi Sankyo Inc.
$563
Bayer HealthCare Pharmaceuticals Inc.
$555
Ipsen Biopharmaceuticals, Inc
$466
Boehringer Ingelheim Pharmaceuticals, Inc.
$431
Gilead Sciences, Inc.
$356
EMD Serono, Inc.
$339
Clovis Oncology, Inc.
$329
Teva Pharmaceuticals USA, Inc.
$315
TerSera Therapeutics LLC
$314
Seattle Genetics, Inc.
$313
Pharmacyclics LLC, An AbbVie Company
$288
Rigel Pharmaceuticals, Inc.
$268
Kyowa Kirin, Inc.
$258
NOVARTIS PHARMACEUTICALS CORPORATION
$250
BeiGene USA, Inc.
$240
TESARO, Inc.
$231
PharmaEssentia USA Corporation
$213
Taiho Oncology, Inc.
$209
ABBVIE INC.
$207
PUMA BIOTECHNOLOGY, INC.
$195
TAIHO ONCOLOGY, INC.
$174
Foundation Medicine, Inc.
$171
Heron Therapeutics, Inc.
$166
Genmab U.S., Inc.
$160
ARRAY BIOPHARMA INC
$160
TOLMAR Pharmaceuticals, Inc.
$156
JAZZ PHARMACEUTICALS INC.
$150
Sun Pharmaceutical Industries Inc.
$150
Janssen Scientific Affairs, LLC
$145
Regeneron Healthcare Solutions, Inc.
$139
AbbVie Inc.
$124
Kite Pharma, Inc.
$121
Dova Pharmaceuticals
$120
Bayer Healthcare Pharmaceuticals Inc.
$119
Blueprint Medicines Corporation
$118
Pharmacyclics LLC, an AbbVie Company
$102
MorphoSys, US Inc.
$98
SANOFI-AVENTIS U.S. LLC
$98
Pharmacosmos Therapeutics Inc.
$97
EISAI INC.
$95
Sobi, Inc
$86
EUSA Pharma (US) LLC
$85
Spectrum Pharmaceuticals Inc.
$84
Deciphera Pharmaceuticals Inc.
$79
Agios Pharmaceuticals, Inc.
$76
AbbVie, Inc.
$76
Stemline Therapeutics Inc.
$75
Myovant Sciences Inc.
$70
Mirati Therapeutics, Inc.
$70
Lexicon Pharmaceuticals, Inc.
$61
ImmunoGen, Inc.
$56
INTUITIVE SURGICAL, INC.
$56
Novocure Inc.
$47
Apellis Pharmaceuticals, Inc.
$46
Global Blood Therapeutics, Inc.
$41
Sirtex Medical Inc
$35
Secura Bio, Inc.
$32
Immunocore Limited
$32
Helsinn Therapeutics (U.S.), Inc.
$31
SOBI, INC
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$28
SpringWorks Therapeutics, Inc.
$26
Jazz Pharmaceuticals Inc.
$23
Sumitomo Pharma America, Inc.
$23
Mylan Institutional Inc.
$21
G1 Therapeutics, Inc.
$21
Tolmar, Inc.
$21
Fennec Pharmaceuticals, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$17
Shire North American Group Inc
$16
Cumberland Pharmaceuticals, Inc.
$16
GE HEALTHCARE
$15
Advanced Accelerator Applications
$15
Top 3 companies account for 21.9% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYNFEZIA PEN · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Trodelvy · Truxima · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
294
Per 100K population
3.0
County median income
$87,760
Nearest hospital
VALLEY PRESBYTERIAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vasan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vasan experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Vasan performed 810 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vasan receive payments from pharmaceutical companies?
Yes. Dr. Vasan received a total of $39,536 from 95 companies across 1,592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vasan's costs compare to other hematology & oncology specialists in Van Nuys?
Dr. Vasan's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vasan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Van Nuys
Browse hematology & oncology specialists in Van Nuys ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology